Global Medical Implant Market Outlook, 2029

The Global Medical Implants Market is projected to grow at a 7% CAGR from 2024 to 2029. Technological advancements and rising healthcare expenditures are fueling market expansion.

The global medical implant market is expected to experience significant growth in the coming years. This growth is being driven by a number of factors, including an aging population, a rise in chronic diseases, and increasing demand for minimally invasive procedures. An aging population is a key driver of the medical implant market. As people live longer, they are more likely to require implants to replace or repair damaged joints, bones, and other tissues. As per the World Social Report 2023, the number of adults aged 65 and older is expected to more than quadruple, going from 761 million to 1.6 billion globally between 2021 and 2050. This increase in the elderly population is expected to lead to a surge in demand for orthopedic implants, in particular, as this age group is more susceptible to conditions like arthritis. Furthermore, the rising prevalence of chronic diseases such as cardiovascular diseases, orthopedic disorders, and dental ailments is another major factor propelling the market forward. Chronic diseases often require implant-based treatment or intervention, and with the global burden of these conditions on the rise, the demand for medical implants is anticipated to grow in tandem. For instance, according to the American Cancer Society, 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States in 2023 compared to 287,850 new breast cancer cases in 2022. This rise in breast cancer cases is expected to fuel the demand for breast implants for breast augmentation procedures. According to the research report, “Global Medical Implants Market Outlook, 2029” published by Bonafide Research, the market is anticipated to grow with 7% CAGR by 2024-29. Technological advancements are also playing a crucial role in shaping the medical implant market. The development of new biomaterials, improved design and functionality of implants, and the growing adoption of minimally invasive surgical techniques are all contributing to market growth. These advancements are leading to the creation of more effective and long-lasting implants, which is improving patient outcomes and driving up adoption rates. However, the medical implant market also faces some challenges. The high cost of implants and associated procedures can be a barrier to access for some patients. Additionally, stringent regulatory requirements can slow down the development and approval of new implant technologies. Despite these challenges, the global medical implant market is poised for continued growth in the years to come. The aging population, rising burden of chronic diseases, and technological advancements are all expected to create significant demand for these medical devices.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market DriversAging Population: As people live longer, the demand for implants to replace or repair damaged joints, bones, and tissues increases. This is especially true for orthopedic implants, catering to the growing elderly population susceptible to conditions like arthritis. • Rise in Chronic Diseases: The growing prevalence of chronic illnesses like cardiovascular diseases, orthopedic disorders, and dental ailments fuels the market. Many chronic conditions require implant-based treatments, leading to a corresponding rise in implant demand. For instance, the increasing number of breast cancer diagnoses is expected to drive demand for breast implants. • Technological Advancements: Developments in biomaterials, improved implant design and functionality, and the adoption of minimally invasive surgical techniques are propelling the market forward. These advancements create more effective and long-lasting implants, improving patient outcomes and increasing adoption rates. Market Challenges

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

High Costs: The high cost of implants and related procedures can be a significant barrier to access for some patients. This can limit the overall market potential and create disparities in healthcare access. • Stringent Regulations: Strict regulatory requirements can slow down the development and approval process for new implant technologies. This can stifle innovation and delay patients' access to potentially life-changing advancements. • Reimbursement Issues: Reimbursement policies from insurance companies can be complex and unpredictable, making it difficult for hospitals and patients to budget for implant procedures. This uncertainty can create challenges in treatment planning and access to care. Market TrendsFocus on Minimally Invasive Procedures: Minimally invasive surgical techniques are becoming increasingly popular due to their benefits like faster recovery times and less pain for patients. This trend is driving the development of implants specifically designed for these procedures. • Personalized and Patient-Specific Implants: The rise of 3D printing and other technologies is enabling the creation of customized implants tailored to individual patients' anatomy. This trend is expected to improve implant fit and function, leading to better patient outcomes. • Digitalization and Remote Monitoring: The integration of digital technologies like remote monitoring of implants is gaining traction. This allows for better tracking of implant performance and potential issues, potentially reducing revision surgeries and improving patient care.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Orthopedic implants lead the medical implant industry primarily due to the high prevalence of musculoskeletal disorders and injuries, particularly in an aging population. Orthopedic implants dominate the medical implant industry largely because of the widespread incidence of musculoskeletal conditions and injuries, which have escalated due to several demographic and lifestyle factors. As the global population ages, the prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis increases. These conditions often necessitate surgical interventions involving implants to restore mobility, relieve pain, and improve the quality of life. Orthopaedic implants, including joint replacements (such as hip, knee, and shoulder), spinal implants, and fracture fixation devices, are essential in treating these disorders. One of the most significant contributors to the dominance of orthopedic implants is the aging demographic. According to the World Health Organization (WHO), the proportion of the global population over 60 years is expected to nearly double from 12% to 22% between 2015 and 2050. Older adults are more susceptible to degenerative diseases and fractures due to reduced bone density and other age-related changes. Consequently, the demand for joint replacement surgeries, which involve orthopedic implants, has surged. For instance, hip and knee replacements are among the most common and successful surgeries performed on the elderly, significantly driving the orthopedic implant market. Additionally, the increase in life expectancy means that people are living longer with chronic conditions that affect their mobility and quality of life. Orthopaedic implants play a crucial role in enabling these individuals to maintain an active and independent lifestyle. Innovations in implant materials and surgical techniques have also made these procedures more effective and accessible, further fueling their popularity. Apart from the aging population, the rise in sports-related injuries and road accidents has also contributed to the demand for orthopedic implants. Athletes and physically active individuals are at higher risk of injuries such as fractures, ligament tears, and joint dislocations. The need for prompt and effective treatment to ensure a quick return to activity makes orthopedic implants indispensable in sports medicine. Similarly, the increasing number of road traffic accidents worldwide necessitates the use of trauma implants to treat fractures and other severe injuries. lifestyle-related factors such as obesity and a sedentary lifestyle contribute to the rising incidence of musculoskeletal disorders. Excessive body weight exerts additional stress on the joints, particularly the knees and hips, accelerating the wear and tear of cartilage and leading to conditions that require surgical intervention. The growing awareness of health and fitness has paradoxically led to an increase in joint-related problems as more individuals engage in physical activities that can lead to injuries. Technological advancements have also played a pivotal role in the growth of the orthopedic implant market. Innovations such as minimally invasive surgical techniques, computer-assisted orthopedic surgery (CAOS), and 3D-printed implants have improved the precision and outcomes of implant surgeries. These advancements have reduced recovery times, minimized surgical risks, and enhanced the longevity and functionality of implants, making them a more attractive option for patients and healthcare providers. Metallic biomaterials lead the medical implant industry primarily due to their superior mechanical properties, such as strength, durability, and biocompatibility, which make them ideal for load-bearing applications in orthopedic and dental implants. Metallic biomaterials are at the forefront of the medical implant industry due to their exceptional mechanical properties, which are essential for applications that require significant load-bearing capacity and durability. These materials, including titanium, stainless steel, and cobalt-chromium alloys, possess a unique combination of strength, toughness, and resistance to fatigue and corrosion, making them highly suitable for orthopedic, dental, and cardiovascular implants. The primary reason for the dominance of metallic biomaterials is their mechanical strength and durability. Implants such as joint replacements (hip, knee, and shoulder), spinal implants, and fracture fixation devices must withstand the substantial mechanical stresses and strains exerted by daily activities. Metallic biomaterials can bear these loads without deforming or failing, ensuring the long-term stability and functionality of the implants. For instance, titanium and its alloys are widely used in orthopedic implants due to their high tensile strength, low density, and excellent fatigue resistance. These properties enable the implants to perform effectively under continuous and varying loads, which is critical for the success of procedures like joint replacements. Additionally, metallic biomaterials exhibit superior biocompatibility, which is crucial for the integration and longevity of implants within the human body. Metals such as titanium are known for their ability to form a stable oxide layer on their surface, which minimizes the risk of adverse reactions and promotes osseointegration. Osseointegration is the direct structural and functional connection between living bone and the surface of an implant, which is vital for the stability and long-term success of orthopedic and dental implants. Titanium's biocompatibility and its ability to bond with bone tissue make it a preferred choice for these applications. The corrosion resistance of metallic biomaterials also contributes to their leading position in the medical implant industry. Human body fluids are corrosive environments, and the ability of metals like titanium and cobalt-chromium alloys to resist corrosion ensures the longevity and safety of the implants. Corrosion can lead to the release of metal ions, which may cause local and systemic reactions, compromising the implant's integrity and the patient's health. The excellent corrosion resistance of these metals helps maintain the structural integrity of implants over extended periods, reducing the risk of complications and the need for revision surgeries. The versatility and workability of metallic biomaterials facilitate their use in a wide range of medical applications. Metals can be easily fabricated into complex shapes and customized to meet specific patient needs. Advanced manufacturing techniques, such as additive manufacturing (3D printing), allow for the precise creation of patient-specific implants with intricate geometries that enhance fit and function. This adaptability is particularly important in orthopedics and dentistry, where individualized solutions can significantly improve patient outcomes. The well-established history and extensive clinical experience with metallic biomaterials further reinforce their dominance in the medical implant industry. Decades of research and clinical use have provided a wealth of data on their performance, safety, and long-term outcomes. This extensive knowledge base instills confidence in both healthcare providers and patients, ensuring that metallic biomaterials remain the material of choice for many implant applications. North America is leading in the medical implant industry primarily due to its advanced healthcare infrastructure, substantial investment in research and development, and a strong regulatory framework that ensures the safety and efficacy of medical implants. North America's dominance in the medical implant industry is underpinned by several key factors that collectively create an environment conducive to innovation, quality, and accessibility. At the forefront is the region's advanced healthcare infrastructure, which includes a vast network of highly specialized hospitals, clinics, and research institutions. These facilities are equipped with state-of-the-art technology and staffed by skilled healthcare professionals who are adept at utilizing the latest medical advancements. This infrastructure not only supports the development and testing of new implants but also ensures that patients have access to the most cutting-edge treatments. The regulatory framework in North America, particularly the role of the U.S. Food and Drug Administration (FDA), plays a pivotal role in the industry's leadership. The FDA's stringent approval process ensures that medical implants meet high standards of safety and efficacy before they reach the market. This rigorous oversight not only protects patients but also instills confidence in healthcare providers and consumers. Moreover, the regulatory environment encourages companies to continuously improve their products to meet evolving standards, driving further innovation and quality improvements. North America's favorable economic conditions and supportive policy landscape also contribute to the industry's success. Governments in the region provide various incentives for medical research, including grants, tax credits, and funding for public health initiatives. These incentives lower the financial barriers to innovation and encourage companies to invest in the development of new and improved medical implants. Additionally, the presence of a robust venture capital ecosystem ensures that startups and smaller companies have access to the necessary funding to bring their innovations to market. Patient demographics and demand dynamics further bolster North America's leadership in the medical implant industry. The region has a large and aging population, which drives demand for medical implants to address age-related conditions such as osteoarthritis, cardiovascular diseases, and neurological disorders. High levels of health awareness and insurance coverage also mean that patients are more likely to seek advanced medical treatments, including implants, contributing to a strong and consistent market demand. • A study published by the Icahn School of Medicine at Mount Sinai in May 2023 demonstrated the safety and efficacy of first-generation BVS as alternatives to drug-eluting metallic stents for coronary artery disease. This paves the way for further development and clinical use of BVS technology by interventional cardiologists, potentially improving patient outcomes. • DeGen Medical, Inc., a US-based company, launched the Impulse AM implant in February 2022. This implant is a 3D-printed, porous titanium device used for posterior interbody fusion in spinal surgeries. The porous structure allows for bone ingrowth, potentially promoting better long-term stability and fusion rates. • While not a specific product, the application of generative artificial intelligence (GenAI) in medical device manufacturing is a noteworthy trend. Companies are exploring GenAI's potential to improve efficiency throughout the manufacturing process. For instance, GenAI can be used to create ""digital factory twins"" that allow for virtual simulations and optimization of production lines. This technology, still under development, has the potential to streamline manufacturing, reduce costs, and improve the quality of medical implants. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Medical Implant market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product • Orthopedic Implant • Cardiovascular Implant • Ophthalmic Implants • dental Implants • Facial Implants • Breast Implants • Other Implants The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Medical Implant industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

Request Table of Contents

First Name

Last Name

Company Name

Job Title

Business Email

Contact Number

Description
Logo

Global Medical Implant Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.